Attached files
| file | filename |
|---|---|
| EX-99.2 - INVESTOR SLIDES - WEST PHARMACEUTICAL SERVICES INC | slides.htm |
| 8-K - CJS SECURITIES CONFERENCE - WEST PHARMACEUTICAL SERVICES INC | file8kcjs.htm |
Exhibit 99.1
|
Contacts:
West
Pharmaceutical Services, Inc.
Michael
A. Anderson
Vice
President and Treasurer
(610)
594-3345
|
Investors and Financial Media:
Westwicke
Partners
John
Woolford/Stefan Loren
(443)
213-0506/0507
|
West
to Present at CJS Securities Investor Conference
LIONVILLE, Pa., January 7, 2010 -- West
Pharmaceutical Services, Inc. (NYSE: WST) today announced that Donald E. Morel, Jr., Ph.D.,
Chairman and Chief Executive Officer, and William Federici, Chief Financial
Officer, will attend CJS Securities’ 10th Annual “New Ideas for the New Year”
investor conference in New York, NY. Management will present an
overview of West's business and outlook on Thursday, January 14, 2010 at 4:00 PM
ET.
About
West
West is a
global manufacturer of components and systems for injectable drug delivery,
including stoppers and seals for vials, and closures and disposable components
used in syringe, IV and blood collection systems. The Company also provides
products with application to the personal care, food and beverage markets.
Headquartered in Lionville, Pennsylvania, West supports its partners and
customers from 50 locations throughout North America, South America, Europe,
Mexico, Japan, Asia and Australia. For more information, visit West at www.westpharma.com.